Open Forum Infectious
Podcast 13: An interview with Dr. Brad Spellberg
In this thirteenth installment of the OFID podcast, Editor Paul Sax, MD, and Brad Spellberg, MD, discuss messaging and managing antibiotic stewardship. They delve into why it continues to be such a hot topic and how to convince hospital executives that the work is worthwhile, also well some of Dr. Spellberg’s all-time favorite misguided statements that people make on the subject.
Podcast 12: An interview with Dr. James Cherry
In this twelfth installment of the OFID podcast, Editor Paul Sax, MD, discusses pertussis epidemiology and prevention with James Cherry, MD. Dr. Cherry breaks down the evolution of pertussis vaccines over time, how to protect and prevent infection in those most at risk, and whether infections are truly on the rise.
Podcast 11: An interview with Dr. Sherwood Gorbach
In the eleventh installment of the OFID podcast, Editor Paul Sax, MD, explores the ins-and-outs of manning the helm of one of the leading journals in ID – Clinical Infectious Diseases – with Sherwood Gorbach, MD. He will have held the Editor-in-Chief position for 17 years when he retires in December. Dr. Gorbach divulges the biggest challenges of the job, what it was like before electronic publishing, and how the journal has dealt with sticky subjects, such as conflicts of interest and retractions.
Podcast 10: An interview with Drs. Wendy Armstrong and Michael Edmond
In the tenth installment of the OFID podcast, Editor Paul Sax, MD, interviews Wendy Armstrong, MD, and Michael Edmond, MD, MPH, to debate the root cause of the unsettling decline in infectious disease fellowship applicants. The trio explores how the lack of salary parity, less exposure to infectious diseases doctors during residency, and increasing educational debt burden are contributing to the problem.
Podcast 9: An interview with Dr. Duane Gubler
In the ninth installment of the Open Forum Infectious
Podcast 8: An interview with Drs. Aaron Kesselheim and Joel Gallant
In the eighth installment of the OFID podcast, Editor Paul Sax, MD, delves into the headline-making pyrimethamine (Daraprim) saga where Turing Pharmaceuticals increased the price of the recently-acquired toxoplasmosis drug from $13 to $750 a pill. Aaron Kesselheim, MD, JD, MPH, and Joel Gallant, MD, MPH, join the discussion to shed light on what is unique about the generic drug market in the U.S. that makes these dramatic price increases possible and if there will be any resolution.
Podcast 7: An interview with Dr. Angela Caliendo
In this seventh installment of the Open Forum Infectious
Podcast 6: An interview with Dr. Martin Blaser
In this sixth installment of the Open Forum Infectious
Podcast 5: An interview with Seth Mnookin
In this fifth installment of the Open Forum Infectious
Podcast 4: An interview with Dr. Paul Farmer
In this fourth installment of the Open Forum Infectious
Podcast 3: An interview with Dr. Deborah Cotton
In this third installment of the Open Forum Infectious Diseases podcast, Editor in Chief Paul Sax, MD, speaks with colleague Deborah Cotton, MD, MPH, about the recent OFID article “A Glimpse of the Early Years of the Human Immunodeficiency Virus Epidemic: A Fellow's Experience in 2014.” Drs. Sax and Cotton compare their experiences in Boston (at Brigham and Women’s Hospital and Boston University Hospital, respectively) with those of the authors at Atlanta’s Grady Hospital, which still cares for a large number of patients with untreated HIV.
Podcast 2: An interview with Dr. John Bartlett
In the second Open Forum Infectious
Podcast 1: An Interview with Dr. Samuel L. Katz
In the first Open Forum Infectious